ENHANCING TUMOR VACCINE IMMUNOGENICITY BY ANTIGAL

$202,913R01FY2000CANIH

Rush University Medical Center, Chicago IL

Investigators

Linked publications & trials

Paper 18047841 Paper 15921377 Paper 15818383 Paper 12821349 Paper 11886847 Paper 11522233 Paper 11447137

View original record on NIH RePORTER →